GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
Company Details
Gc Therapeutics Questions
Gc Therapeutics's website is gc-tx.com
Gc Therapeutics's LinkedIn profile is https://www.linkedin.com/company/gctx
Gc Therapeutics has
43 employees.
View email and phone details for 43
employees at Gc Therapeutics.
Gc Therapeutics's industry is
Biotechnology Research
Gc Therapeutics's top competitors are
Delphia Therapeutics,
Seaport Therapeutics,
Tessera Therapeutics,
Cellino,
Quiver Bioscience,
Nuvalent, Inc.,
Myrobalan Therapeutics,
Pledge Therapeutics,
Nvelop Therapeutics,
Airna.
Gc Therapeutics's categories are Biotechnology Research
